A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Clinical trial NCT03715829 · COMPLETED

Trial details

NCT number: NCT03715829
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Active Non-segmental Vitiligo

Start date: 2018-11-26
Primary completion: 2021-02-05
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.